Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Jason C Gallagher"'
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Antibiotic prescribing errors at hospital discharge are common. We designed a pharmacist-driven antimicrobial stewardship program to evaluate prescriptions prior to being transmitted to community pharmacies. Drug-related problems were identified in p
Externí odkaz:
https://doaj.org/article/29678fabb0f84c45aed2d6d484792b47
Autor:
Carly E. Sedlock, Marissa J. Cavaretta, Alexander J. Haines, Kevin B. Nguyen, Neelesh Agarwal, Jason C. Gallagher
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Antibiotic stewardship initiatives usually occur in the inpatient setting and should be optimized during transitions of care. In this study, we assessed the appropriateness of oral antibiotic treatment duration at the time of discharge from our insti
Externí odkaz:
https://doaj.org/article/5cf70236db92450f8b5dcf16c8675e13
Autor:
Tristan Ferry, Thomas P. Lodise, Jason C. Gallagher, Emmanuel Forestier, Sylvain Goutelle, Vincent H. Tam, John F. Mohr, Claire Roubaud-Baudron
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Since the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has been a viable option for patients who require intravenous antibiotics when hospitalization is not warranted. While the benefits of OPAT as a measure to improve the efficiency of
Externí odkaz:
https://doaj.org/article/ddd81a920ca34ffd99790d7ba626a2e1
Autor:
Jason C Gallagher, Torey Roesch, Julie Giurintano, Abby Atwater, Anya Dinh, Liesel Groninger, Julie Hoang, Jennifer Shif, Erin Tanasy, Jamie Wagner, Maria Bandres, Jacqueline Burnell
Publikováno v:
Open Forum Infectious Diseases. 9
Background Lung transplant patients (LTPs) experience considerable infection-related morbidity and mortality, including from pneumonia. Our institution performs the highest volume of lung transplants in the US, providing an opportunity to describe th
Autor:
Jason C. Gallagher, Yngve Falck-Ytter, William J. Muller, Shmuel Shoham, Adarsh Bhimraj, John C. O’Horo, Lindsey R. Baden, Dana Swartzberg Wollins, Rajesh T. Gandhi, Amy Hirsch Shumaker, Vincent C.C. Cheng, Valery Lavergne, Kathryn M. Edwards, Rebecca L. Morgan
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Given the urgent need for treatments during the coronavirus disease 2019 pandemic, the US Food and Drug Administration issued emergency use authorizations (EUAs) for multiple therapies. In several instances, however, these EUAs were issued before suf
Autor:
Amy Hirsch Shumaker, Rajesh T. Gandhi, Kathryn M. Edwards, Vincent C.C. Cheng, Rebecca L. Morgan, Jason C. Gallagher, Lindsey R. Baden, William J. Muller, Adarsh Bhimraj, Dana Swartzberg Wollins, Yngve Falck-Ytter, John C. O’Horo, Shmuel Shoham
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Despite the challenges of the pandemic, there has been substantial progress with coronavirus disease 2019 (COVID-19) therapies. Pivotal COVID-19 trials like SOLIDARITY, RECOVERY, and ACCT-1 were rapidly conducted and data disseminated to support effe
Autor:
Jonathan H Ryder, Steven Y C Tong, Jason C Gallagher, Emily G McDonald, Irani Thevarajan, Todd C Lee, Nicolás W Cortés-Penfield
Publikováno v:
Open forum infectious diseases. 9(11)
Background Based primarily on in vitro and animal models, with little data directly addressing patient outcomes, current guidelines recommend treating staphylococcal prosthetic valve endocarditis (PVE) with antibiotic combinations including gentamici
Autor:
Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Lindsey R Baden, Vincent Chi-Chung Cheng, Kathryn M Edwards, Jason C Gallagher, Rajesh T Gandhi, William J Muller, Mari M Nakamura, John C O’Horo, Robert W Shafer, Shmuel Shoham, M Hassan Murad, Reem A Mustafa, Shahnaz Sultan, Yngve Falck-Ytter
Publikováno v:
Clinical Infectious Diseases.
There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials. The objective was to develop evidence-based, rapid, living
Autor:
Jason C. Gallagher, Rebecca L. Morgan
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
Autor:
Adarsh, Bhimraj, Rebecca L, Morgan, Amy Hirsch, Shumaker, Lindsey, Baden, Vincent Chi Chung, Cheng, Kathryn M, Edwards, Jason C, Gallagher, Rajesh T, Gandhi, William J, Muller, Mari M, Nakamura, John C, O'Horo, Robert W, Shafer, Shmuel, Shoham, M Hassan, Murad, Reem A, Mustafa, Shahnaz, Sultan, Yngve, Falck-Ytter
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials.Develop evidence-based, rapid, living guidelines intended to